Houston, Texas — Pfizer is asking the Food and Drug Administration for full approval of its vaccine for individuals 16 and older, which might permit direct advertising to customers and make it simpler for employers to require vaccinations for staff.
“The FDA will move as expeditiously as possible without compromising its gold standard for safety,” stated White House COVID-19 response coordinator Jeff Zients.
The company is anticipated subsequent week to authorize giving the Pfizer shot to 12 to fifteen year olds. Pfizer is prone to search emergency use authorization for its vaccine for kids as younger as 2 in September. But lower than a 3rd of fogeys say they’d get their kids vaccinated when they’re eligible, in accordance with a recent survey.
Pediatric organ transplant surgeon Thao Galvan acquired her 16-month-old son, Nathan, vaccinated. He was the primary baby underneath 2 to obtain the Pfizer vaccine in a examine run by Texas Children’s Hospital, the place Galvan works.
“Having understood the data and the science and the risks involved, we felt that the benefits far outweigh the risks and so that was why the decision was clearer for me,” she stated.
Nathan was given one-tenth of an grownup dose.
“By the end of the day he was having a dance party with his brother so everything was fine,” Galvan stated. “He had two hives by his knee, but he has hives every other day, honestly.”
Her older son, Charlie, is enrolled in section two of the Pfizer trial for his age group.
As the trial for kids progresses at Texas Children’s Hospital, the Houston Health Department tells CBS News some 51,000 individuals who acquired their first shot haven’t returned for the second, which might have an effect on herd immunity.
© 2021 CBS Interactive Inc. All Rights Reserved.